切换导航
News
All Journals
All Articles
Subscribe
Sign up for updates about the journal.
Subscribe
Sign in
Register
Exploration of Targeted Anti-tumor Therapy
切换导航
3.1
CiteScore
PubMed
Indexed
Submit Manuscript
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
About
About the Journal
Editorial Board
Editorial Policies
News & Announcements
Contact Us
Articles
Special Issue
All Special Issues
Guest Editor Guidelines
For Authors
Author Instructions
Editorial Process
Article Processing Charge
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Reviewer Acknowledgment
To Be a Reviewer
Focus
Search
All Journals
Exploration of Medicine
Exploration of Targeted Anti-tumor Therapy
Exploration of Immunology
Exploration of Neuroprotective Therapy
Exploration of Digestive Diseases
Exploration of Neuroscience
Exploration of Musculoskeletal Diseases
Exploration of Drug Science
Exploration of Asthma & Allergy
Exploration of Foods and Foodomics
Exploration of Digital Health Technologies
Exploration of Cardiology
Exploration of BioMat-X
Exploration of Endocrine and Metabolic Diseases
All
Article Title
Abstract
Author
Keywords
Institution
Home
/
Exploration of Targeted Anti-tumor Therapy
/
Articles
/
t2
From:
Medicinal chemistry advances in targeting class I histone deacetylases
Table 2.
Structures of clinically approved HDAC inhibitors
Name
Structure
Vorinostat
Tucidinostat
Romidepsin
Panobinostat
Belinostat
Return to article view
